Researchers from Chulalongkorn University, a public university in Thailand, have created an AI-based system for detecting gastrointestinal disorders.
WHAT IT DOES
DeepGI (Deep Technology for Gastrointestinal Tracts) spots abnormal tissues indicative of early colonic neoplasm, such as polyps, in the colon with over 90% accuracy, according to Dr Peerapon Vateekul, a member of the research team from...
Shanghai-based startup Wision AI has received Europe's CE mark for its AI-enabled polyp detection software used in colonoscopy.
WHAT IT DOES
The startup describes its EndoScreener as a real-time computer-aided diagnosis software that assists endoscopists by simultaneously notifying and sounding an alarm when a polyp has been detected during colonoscopy.
Based on a study, the software device has...
A new clinical validation study, published in the Journal of Clinical Oncology CCI, found that Medial EarlySign’s artificial intelligence tool flagged about 8 percent of patients in a large trial group that were later diagnosed with cancer or precancerous lesions.
“The implementation of machine-learning based algorithms to risk stratify populations at risk is commonly feared by many clinicians...
A trio of presenters at HIMSS 2018 shared data from practical machine learning and AI-focused studies that demonstrate how the technologies could reduce costs and improve patients’ outcomes.
These studies, conducted by teams at the Grady Health System, Kaiser Permanente, and the University of Pittsburgh Medical Center, primarily focused on flagging adult and pediatric patients whose EHRs...
Israel-based Check-Cap, a clinical stage medical diagnostics company that is working on an ingestible sensor capsule to screen for colorectal cancer, has entered into an agreement with a single healthcare company for $5.9 million in financing. Check-Cap, which does not have a commercial product as of yet, will use the net proceeds from the offering to advance the ongoing clinical development of...
